Literature DB >> 18270484

Merged imaging and expanded target selection in gamma knife radiosurgical ablation of the sphenopalatine ganglion.

Chris Karas1, Mirza N Baig, Timothy Larson, Wayne Slone, Reinhard Gahbauer, John M McGregor.   

Abstract

Sphenopalatine neuralgia, or Sluder's neuralgia, refers to a consistent clustering of clinical symptoms: intermittent episodes of vasomotor hyperactivity causing conjuctival injection, lacrimation, serous nasal discharge and unilateral nasal mucosal inflammation, sensory disturbances of the palate and oropharynx with distorted gustatory sensations, and lancing, unilateral pain most often located in the area of the inferomedial orbit and nasal base or at the region of the mastoid process. This particular clinical entity has also proven difficult to manage effectively, especially when not clearly secondary to other medical conditions such as paranasal sinus infection or bony nasal deformities. This condition has been treated with success using Gamma Knife radiosurgery in at least 1 other case reported in the literature. We present a second patient whose sphenopalatine neuralgia was treated successfully with stereotactic radiosurgery and discuss the possibilities of this modality as an option for patients with a refractory condition. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18270484     DOI: 10.1159/000116217

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  2 in total

1.  Resection of the nerves bundle from the sphenopalatine ganglia tend to increase the infarction volume following middle cerebral artery occlusion.

Authors:  Su Diansan; Zhang Shifen; Gu Zhen; Wang Heming; Wang Xiangrui
Journal:  Neurol Sci       Date:  2010-03-03       Impact factor: 3.307

2.  Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia.

Authors:  Ilker Coven; Ezher H Dayısoylu
Journal:  Springerplus       Date:  2016-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.